https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29046 4000 Kcal/day for those weight stable at the highest levels of morbid obesity (up to BMI 97 kgm⁻²). Fat intakes are also high, around 40% of energy intake and up to 57% for some individuals. Suboptimal intakes of iron and calcium are reported. Conclusion: This review draws attention to a limited evidence base, offers preliminary insight suggesting individuals with morbid obesity are prone to consuming poor quality diets similar to those reported for obese populations, and highlights challenges for future research.]]> Wed 06 Apr 2022 14:03:56 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:43994 Wed 05 Oct 2022 14:43:36 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48322 0.05). Within the MedDiet group only, the proportion of participants taking beta-blocker medication reduced from baseline to 6-months (71% vs. 56%, p-trend = 0.007). Conclusions: Adherence to 6-month ad libitum MedDiet reduced subcutaneous fat and waist circumference which discounts the misconception that this healthy but high fat diet leads to body fat gain. The effect of MedDiet on body fat distribution and consequent anti-inflammatory and antioxidant effects, as well as need for medications, in patients with CHD warrants exploration in larger studies. Clinically significant effects on these markers may require adjunct exercise and/or caloric restriction. Trial registration: ACTRN12616000156482.]]> Tue 14 Mar 2023 16:21:47 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47873 Fri 03 Feb 2023 15:04:00 AEDT ]]>